Science:Life Sciences
Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde.
Together, they talk about how AI could transform drug discovery and development at a large biopharma company—and how a company might have to adapt to harness AI; modalities they’re excited about; and Greg’s do’s and don’ts for startups looking to partner with a company like BMS.
More Episodes
The Cost Disease in Healthcare
2020-12-14
2020-12-14
The Google Maps Moment in (Modeling) Biology
2020-12-07
2020-12-07
Journal Club: Bioengineering Birth
2020-12-03
2020-12-03
The Story of Schizophrenia
2020-11-30
2020-11-30
Food as Medicine
2020-11-24
2020-11-24
Health—at What Price?
2020-11-16
2020-11-16
Journal Club: Defeating Type 1 Diabetes
2020-11-12
2020-11-12
We, the Patients
2020-11-09
2020-11-09
The Thermodynamics of Life
2020-11-02
2020-11-02
The Biology of Pain
2020-10-19
2020-10-19
Biology by Design
2020-10-13
2020-10-13
Going Back to the Workplace in a Pandemic
2020-10-06
2020-10-06
Get this podcast on your
phone, FREE
